logo

For the Inventor, By the Inventor

Federal Way, WA, United States of America

Teresa M Foy

This inventor holds 12 USPTO granted patents and 2 published patent applications. Top assignees: Dartmouth College, Corixa Corporation, Bristol-Myers Squibb Compnay. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teresa M Foy. Retrieved from https://idiyas.com/inventor/teresa-m-foy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 58.3

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 271(Granted Patents)


Location History:

  • Seattle, WA (US) (1998 - 2001)
  • Federal Way, WA (US) (1999 - 2009)
  • Lebanon, NH (US) (2009 - 2010)
  • Snoqualmie, WA (US) (2010)

Company Filing History:

goldMedal6 out of 708 
 
Dartmouth College
 patents
silverMedal5 out of 247 
 
Corixa Corporation
 patents
bronzeMedal2 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
4. 2 out of 1,633 
 
University of Massachusetts
 patents
5. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2010

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7749505 - Compositions and methods for the therapy and diagnosis of lung cancer (2010-07-06),
2. 7722874 - Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells (2010-05-25),
3. 7585506 - Compositions and methods for the therapy and diagnosis of lung cancer (2009-09-08),
4. 7476385 - Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 (2009-01-13),
5. 7033827 - Prostate-specific polynucleotide compositions (2006-04-25),
6. 6960570 - Compositions and methods for the therapy and diagnosis of lung cancer (2005-11-01),
7. 6943236 - Compositions and methods for the therapy and diagnosis of prostate cancer (2005-09-13),
8. 6312692 - Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells (2001-11-06),
9. 5942229 - Method for prolonged suppression of humoral immune response to a (1999-08-24),
10. 5876718 - Methods of inducing T cell non-responsiveness to transplanted tissues (1999-03-02),
11. 5869049 - Methods of inducing T cell unresponsiveness to bone marrow with gp39 (1999-02-09),
12. 5747037 - Anti-GP39 antibodies (1998-05-05),

Title: Teresa M Foy - Pioneering Inventor from Federal Way

Introduction: Teresa M Foy is a trailblazing inventor hailing from Federal Way, Washington. With a passion for innovation and a drive to make a difference, she has made significant contributions to the field of technology.

Latest Patents: Teresa M Foy holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices. Her innovative solutions have garnered attention for their practicality and efficiency.

Career Highlights: Throughout her illustrious career, Teresa M Foy has worked with top research institutions and leading tech companies to bring her inventions to life. Her dedication to pushing the boundaries of technology has led to groundbreaking advancements in the industry.

Collaborations: Teresa M Foy has collaborated with renowned inventors, patent attorneys, and research institutions to further her innovative projects. By leveraging the expertise of her peers, she has been able to create cutting-edge solutions that have the potential to revolutionize the way we live and work.

Conclusion: Teresa M Foy's relentless pursuit of innovation and her commitment to making a positive impact on society have solidified her reputation as a pioneering inventor in Federal Way and beyond. Her work continues to inspire future generations of inventors to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…